Menu Search
Equities

Olympus Corp

7733:TYO

Olympus Corp

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,256.00
  • Today's Change65.00 / 2.97%
  • Shares traded3.88m
  • 1 Year change-7.64%
  • Beta0.8670
Data delayed at least 20 minutes, as of May 02 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Olympus Corp grew revenues 17.57% from 750.12bn to 881.92bn while net income improved 23.92% from 115.74bn to 143.43bn.
Gross margin67.08%
Net profit margin4.35%
Operating margin9.07%
Return on assets2.79%
Return on equity5.83%
Return on investment3.75%
More ▼

Cash flow in JPYView more

In 2023, cash reserves at Olympus Corp fell by 97.06bn. However, the company earned 98.49bn from its operations for a Cash Flow Margin of 11.17%. In addition the company used 58.41bn on investing activities and also paid 143.18bn in financing cash flows.
Cash flow per share83.67
Price/Cash flow per share26.17
Book value per share633.64
Tangible book value per share403.77
More ▼

Balance sheet in JPYView more

Olympus Corp has a Debt to Total Capital ratio of 28.89%, a lower figure than the previous year's 49.55%.
Current ratio2.07
Quick ratio1.58
Total debt/total equity0.4063
Total debt/total capital0.2889
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 14.29% and 26.33%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
Div yield(5 year avg)0.62%
Div growth rate (5 year)17.98%
Payout ratio (TTM)50.82%
EPS growth(5 years)21.12
EPS (TTM) vs
TTM 1 year ago		-69.54
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.